Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carbohydrate binding	HEXB CLEC19A ADGRL2 ADGRL3 MRC1 CLEC9A CHODL IGF2R CD22 ASGR1 REG3A LY75	1.00e-04	310	207	12	GO:0030246
GeneOntologyMolecularFunction	complement component C3b receptor activity	CR1 CR1L	1.07e-04	2	207	2	GO:0004877
GeneOntologyMolecularFunction	isocitrate dehydrogenase (NADP+) activity	IDH1 IDH2	1.07e-04	2	207	2	GO:0004450
GeneOntologyMolecularFunction	complement component C4b receptor activity	CR1 CR1L	1.07e-04	2	207	2	GO:0001861
GeneOntologyMolecularFunction	bile-salt sulfotransferase activity	SULT1C4 SULT2A1	3.19e-04	3	207	2	GO:0047704
GeneOntologyMolecularFunction	complement component C4b binding	CR1 CR1L	3.19e-04	3	207	2	GO:0001855
GeneOntologyCellularComponent	cell surface	EPHB6 ADGRV1 CEACAM1 FZD1 FCER1A GPC5 ALCAM IGSF3 MRC1 CLEC9A MYO18A CUBN CR1 CR1L FCRL6 CD200R1 ADGRG6 IGF2R CD6 CD22 PEBP1 ASGR1 PCSK6 TLR2 LRP6 ASTN1 LY75 CEACAM20 KCNH5	2.15e-06	1111	209	29	GO:0009986
GeneOntologyCellularComponent	side of membrane	LRRK2 NCAM2 CNTN6 CEACAM1 FCER1A ALG8 GNA11 GPC5 ALCAM GNAQ DPEP1 CUBN CR1 CR1L ZAP70 FCRL6 CD200R1 CD22 ASGR1 TLR2 CNTN3 ASTN1 LY75	2.37e-05	875	209	23	GO:0098552
GeneOntologyCellularComponent	microvillus membrane	CEACAM1 PTPRH DPEP1 CUBN CEACAM20	3.65e-05	38	209	5	GO:0031528
GeneOntologyCellularComponent	perikaryon	PCSK1 PCSK5 KLHL24 LRRK2 PTPRN FLNA RCVRN NEURL1 ASTN1 SMN1	8.67e-05	223	209	10	GO:0043204
GeneOntologyCellularComponent	translation release factor complex	GSPT2 GSPT1	2.96e-04	3	209	2	GO:0018444
GeneOntologyCellularComponent	Wnt signalosome	LRRK2 FZD1 LRP6	5.01e-04	16	209	3	GO:1990909
Domain	IGc2	NCAM2 CNTN6 CEACAM1 FCER1A HMCN2 ALCAM IGSF3 FCRL6 HMCN1 CD22 CNTN3 MYOM2 CEACAM20	2.31e-06	235	207	13	SM00408
Domain	Ig_sub2	NCAM2 CNTN6 CEACAM1 FCER1A HMCN2 ALCAM IGSF3 FCRL6 HMCN1 CD22 CNTN3 MYOM2 CEACAM20	2.31e-06	235	207	13	IPR003598
Domain	GPCR_2_secretin-like	ADGRB3 GCGR ADGRV1 FZD1 ADGRL2 ADGRL3 ADGRG6	4.36e-06	60	207	7	IPR000832
Domain	GPCR_2-like	ADGRB3 GCGR ADGRV1 FZD1 ADGRL2 ADGRL3 ADGRG6	4.36e-06	60	207	7	IPR017981
Domain	GPCR_2_extracellular_dom	ADGRB3 GCGR ADGRV1 ADGRL2 ADGRL3 ADGRG6	4.83e-06	40	207	6	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRB3 GCGR ADGRV1 ADGRL2 ADGRL3 ADGRG6	4.83e-06	40	207	6	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRB3 GCGR ADGRV1 ADGRL2 ADGRL3 ADGRG6	4.83e-06	40	207	6	PS50227
Domain	G_PROTEIN_RECEP_F2_4	ADGRB3 GCGR ADGRV1 FZD1 ADGRL2 ADGRL3 ADGRG6	4.88e-06	61	207	7	PS50261
Domain	GPCR_2_latrophilin	ADGRL2 ADGRL3 OLFM2	1.32e-05	5	207	3	IPR003924
Domain	7tm_2	ADGRB3 GCGR ADGRV1 ADGRL2 ADGRL3 ADGRG6	1.82e-05	50	207	6	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRB3 GCGR ADGRV1 ADGRL2 ADGRL3 ADGRG6	1.82e-05	50	207	6	PS00650
Domain	Znf_C2HC	MYT1L L3MBTL1 ST18	2.62e-05	6	207	3	IPR002515
Domain	zf-C2HC	MYT1L L3MBTL1 ST18	2.62e-05	6	207	3	PF01530
Domain	Peptidase_S8_Asp-AS	PCSK1 PCSK5 PCSK6	2.62e-05	6	207	3	IPR023827
Domain	GPS	ADGRB3 ADGRV1 ADGRL2 ADGRL3 ADGRG6	3.41e-05	34	207	5	SM00303
Domain	GPCR_2_secretin-like_CS	ADGRB3 GCGR ADGRL2 ADGRL3 ADGRG6	3.41e-05	34	207	5	IPR017983
Domain	GPS	ADGRB3 ADGRV1 ADGRL2 ADGRL3 ADGRG6	3.95e-05	35	207	5	PF01825
Domain	GPS	ADGRB3 ADGRV1 ADGRL2 ADGRL3 ADGRG6	4.54e-05	36	207	5	PS50221
Domain	P_proprotein	PCSK1 PCSK5 PCSK6	4.54e-05	7	207	3	PF01483
Domain	S8_pro-domain	PCSK1 PCSK5 PCSK6	4.54e-05	7	207	3	IPR032815
Domain	PrprotnconvertsP	PCSK1 PCSK5 PCSK6	4.54e-05	7	207	3	IPR002884
Domain	ZF_CCHHC	MYT1L L3MBTL1 ST18	4.54e-05	7	207	3	PS51802
Domain	-	PCSK1 PCSK5 PCSK6	4.54e-05	7	207	3	3.30.70.850
Domain	S8_pro-domain	PCSK1 PCSK5 PCSK6	4.54e-05	7	207	3	PF16470
Domain	GPS	ADGRB3 ADGRV1 ADGRL2 ADGRL3 ADGRG6	5.20e-05	37	207	5	IPR000203
Domain	IG	NCAM2 CNTN6 CEACAM1 FCER1A HMCN2 ALCAM IGSF3 FCRL6 CD200R1 SEMA3D HMCN1 CD22 CNTN3 MYOM2 CEACAM20	7.49e-05	421	207	15	SM00409
Domain	Ig_sub	NCAM2 CNTN6 CEACAM1 FCER1A HMCN2 ALCAM IGSF3 FCRL6 CD200R1 SEMA3D HMCN1 CD22 CNTN3 MYOM2 CEACAM20	7.49e-05	421	207	15	IPR003599
Domain	Peptidase_S8_His-AS	PCSK1 PCSK5 PCSK6	1.07e-04	9	207	3	IPR022398
Domain	Peptidase_S8_Ser-AS	PCSK1 PCSK5 PCSK6	1.07e-04	9	207	3	IPR023828
Domain	C-type_lectin_CS	MRC1 CLEC9A ASGR1 REG3A LY75	1.09e-04	43	207	5	IPR018378
Domain	Ig-like_fold	EPHB6 NCAM2 CNTN6 CEACAM1 FCER1A HMCN2 PTPRH ALCAM IGSF3 FLNA FCRL6 CD200R1 SEMA3D HMCN1 CD22 CNTN3 ASTN1 MYOM2 ANKFN1 CEACAM20	1.19e-04	706	207	20	IPR013783
Domain	Isocitrate_DH_NADP	IDH1 IDH2	1.22e-04	2	207	2	IPR004790
Domain	Peptidase_S8_subtilisin-rel	PCSK1 PCSK5 PCSK6	1.52e-04	10	207	3	IPR015500
Domain	SUBTILASE_ASP	PCSK1 PCSK5 PCSK6	1.52e-04	10	207	3	PS00136
Domain	SUBTILASE_HIS	PCSK1 PCSK5 PCSK6	1.52e-04	10	207	3	PS00137
Domain	SUBTILASE_SER	PCSK1 PCSK5 PCSK6	1.52e-04	10	207	3	PS00138
Domain	HormR	ADGRB3 GCGR ADGRL2 ADGRL3	1.54e-04	25	207	4	SM00008
Domain	CTDL_fold	SUMF1 MRC1 CLEC9A CHODL ASGR1 REG3A LY75	1.90e-04	107	207	7	IPR016187
Domain	-	PCSK1 PCSK5 PCSK6	2.07e-04	11	207	3	3.40.50.200
Domain	NC1_FIB	COL24A1 COL3A1 COL5A2	2.07e-04	11	207	3	PS51461
Domain	Fib_collagen_C	COL24A1 COL3A1 COL5A2	2.07e-04	11	207	3	PD002078
Domain	Peptidase_S8/S53_dom	PCSK1 PCSK5 PCSK6	2.07e-04	11	207	3	IPR000209
Domain	GAIN_dom_N	ADGRB3 ADGRL2 ADGRL3	2.07e-04	11	207	3	IPR032471
Domain	Fib_collagen_C	COL24A1 COL3A1 COL5A2	2.07e-04	11	207	3	IPR000885
Domain	COLFI	COL24A1 COL3A1 COL5A2	2.07e-04	11	207	3	PF01410
Domain	Peptidase_S8	PCSK1 PCSK5 PCSK6	2.07e-04	11	207	3	PF00082
Domain	GAIN	ADGRB3 ADGRL2 ADGRL3	2.07e-04	11	207	3	PF16489
Domain	COLFI	COL24A1 COL3A1 COL5A2	2.07e-04	11	207	3	SM00038
Domain	HRM	ADGRB3 GCGR ADGRL2 ADGRL3	2.44e-04	28	207	4	PF02793
Domain	C_TYPE_LECTIN_1	MRC1 CLEC9A CHODL ASGR1 REG3A LY75	2.62e-04	80	207	6	PS00615
Domain	Quinoprot_gluc/sorb_DH	EML2 EML5 FBXW5	2.74e-04	12	207	3	IPR011041
Domain	Ig_I-set	NCAM2 CNTN6 CEACAM1 HMCN2 HMCN1 CD22 CNTN3 MYOM2 CEACAM20	2.77e-04	190	207	9	IPR013098
Domain	I-set	NCAM2 CNTN6 CEACAM1 HMCN2 HMCN1 CD22 CNTN3 MYOM2 CEACAM20	2.77e-04	190	207	9	PF07679
Domain	Lectin_C	MRC1 CLEC9A CHODL ASGR1 REG3A LY75	3.42e-04	84	207	6	PF00059
Domain	CLECT	MRC1 CLEC9A CHODL ASGR1 REG3A LY75	3.42e-04	84	207	6	SM00034
Domain	OLF	ADGRL2 ADGRL3 OLFM2	3.54e-04	13	207	3	PF02191
Domain	OLF	ADGRL2 ADGRL3 OLFM2	3.54e-04	13	207	3	PS51132
Domain	Olfac-like_dom	ADGRL2 ADGRL3 OLFM2	3.54e-04	13	207	3	IPR003112
Domain	OLF	ADGRL2 ADGRL3 OLFM2	3.54e-04	13	207	3	SM00284
Domain	-	LRRK2 EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 NBAS SEMA3D MAPKBP1	3.56e-04	333	207	12	2.130.10.10
Domain	Myelin_TF	MYT1L ST18	3.64e-04	3	207	2	IPR013681
Domain	DUF4208	CHD1 CHD2	3.64e-04	3	207	2	PF13907
Domain	Latrophilin	ADGRL2 ADGRL3	3.64e-04	3	207	2	PF02354
Domain	DUF4208	CHD1 CHD2	3.64e-04	3	207	2	IPR025260
Domain	MYT1	MYT1L ST18	3.64e-04	3	207	2	PF08474
Domain	DUF4208	CHD1 CHD2	3.64e-04	3	207	2	SM01176
Domain	GPCR_2_latrophilin_rcpt_C	ADGRL2 ADGRL3	3.64e-04	3	207	2	IPR003334
Domain	C_TYPE_LECTIN_2	MRC1 CLEC9A CHODL ASGR1 REG3A LY75	3.64e-04	85	207	6	PS50041
Domain	WD40/YVTN_repeat-like_dom	LRRK2 EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 NBAS SEMA3D MAPKBP1	3.76e-04	335	207	12	IPR015943
Domain	C-type_lectin-like	MRC1 CLEC9A CHODL ASGR1 REG3A LY75	3.88e-04	86	207	6	IPR001304
Domain	IG_LIKE	NCAM2 CNTN6 CEACAM1 FCER1A HMCN2 ALCAM IGSF3 FCRL6 CD200R1 SEMA3D HMCN1 CD22 CNTN3 MYOM2 CEACAM20	3.96e-04	491	207	15	PS50835
Domain	Kringle-like	MRC1 PRSS12 IGF2R LY75	4.13e-04	32	207	4	IPR013806
Domain	-	EPHB6 NCAM2 CNTN6 CEACAM1 FCER1A ALCAM IGSF3 FLNA FCRL6 CD200R1 SEMA3D HMCN1 CD22 CNTN3 ASTN1 MYOM2 ANKFN1 CEACAM20	4.38e-04	663	207	18	2.60.40.10
Domain	FN_type2_col-bd	MRC1 IGF2R LY75	4.46e-04	14	207	3	IPR000562
Domain	FN2_2	MRC1 IGF2R LY75	4.46e-04	14	207	3	PS51092
Domain	FN2_1	MRC1 IGF2R LY75	4.46e-04	14	207	3	PS00023
Domain	fn2	MRC1 IGF2R LY75	4.46e-04	14	207	3	PF00040
Domain	FN2	MRC1 IGF2R LY75	4.46e-04	14	207	3	SM00059
Domain	EGF-like_dom	PCSK5 MEP1B HMCN2 C6 LAMA3 CUBN HMCN1 PCSK6 LRP6 ASTN1	4.78e-04	249	207	10	IPR000742
Domain	Ig-like_dom	NCAM2 CNTN6 CEACAM1 FCER1A HMCN2 ALCAM IGSF3 FCRL6 CD200R1 SEMA3D HMCN1 CD22 CNTN3 MYOM2 CEACAM20	5.09e-04	503	207	15	IPR007110
Domain	Neural_cell_adh	NCAM2 HMCN1	7.23e-04	4	207	2	IPR009138
Domain	G2F	HMCN2 HMCN1	7.23e-04	4	207	2	PF07474
Domain	NIDOGEN_G2	HMCN2 HMCN1	7.23e-04	4	207	2	PS50993
Domain	GFP	HMCN2 HMCN1	7.23e-04	4	207	2	IPR009017
Domain	Gprotein_alpha_Q	GNA11 GNAQ	7.23e-04	4	207	2	IPR000654
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	7.23e-04	4	207	2	IPR006605
Domain	Propept_inh	PCSK1 PCSK5 PCSK6	8.14e-04	17	207	3	IPR009020
Domain	C-type_lectin-like/link	MRC1 CLEC9A CHODL ASGR1 REG3A LY75	8.21e-04	99	207	6	IPR016186
Domain	WD40	LRRK2 EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 MAPKBP1	8.42e-04	268	207	10	SM00320
Domain	Ser-Thr/Tyr_kinase_cat_dom	EPHB6 NEK6 TXK NEK3 ZAP70 CSK GUCY2F	8.84e-04	138	207	7	IPR001245
Domain	WD40_repeat	LRRK2 EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 MAPKBP1	9.43e-04	272	207	10	IPR001680
Domain	FN3	EPHB6 NCAM2 CNTN6 PTPRH CNTN3 ASTN1 MYOM2 ANKFN1	1.09e-03	185	207	8	SM00060
Domain	WD_REPEATS_1	EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 NBAS MAPKBP1	1.11e-03	278	207	10	PS00678
Domain	WD_REPEATS_2	EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 NBAS MAPKBP1	1.14e-03	279	207	10	PS50082
Domain	WD_REPEATS_REGION	EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 NBAS MAPKBP1	1.14e-03	279	207	10	PS50294
Domain	Isocitrate/isopropylmalate_DH	IDH1 IDH2	1.20e-03	5	207	2	IPR001804
Domain	Gal_Lectin	ADGRL2 ADGRL3	1.20e-03	5	207	2	PF02140
Domain	Iso_dh	IDH1 IDH2	1.20e-03	5	207	2	PF00180
Domain	IsoCit/isopropylmalate_DH_CS	IDH1 IDH2	1.20e-03	5	207	2	IPR019818
Domain	Iso_dh	IDH1 IDH2	1.20e-03	5	207	2	SM01329
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	NCAM2 CNTN6 CEACAM1 PTPRA ALCAM IGSF3 HMCN1 CD22 CNTN3	6.57e-07	162	209	9	25826454
Pubmed	The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.	ADGRB3 ADGRV1 ADGRL2 ADGRL3 ADGRG6	7.89e-07	29	209	5	15203201
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRB3 ADGRV1 ADGRL2 ADGRL3 ADGRG6	1.55e-06	33	209	5	25713288
Pubmed	Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis.	IDH1 IDH2 GSTP1	2.12e-06	5	209	3	25818003
Pubmed	Processing of prothyrotropin-releasing hormone by the family of prohormone convertases.	PCSK1 PCSK5 PCSK6	2.12e-06	5	209	3	9242664
Pubmed	Identification of the paired basic convertases implicated in HIV gp160 processing based on in vitro assays and expression in CD4(+) cell lines.	PCSK1 PCSK5 PCSK6	4.22e-06	6	209	3	8940009
Pubmed	Murine subtilisin-like proteinase SPC6 is expressed during embryonic implantation, somitogenesis, and skeletal formation.	PCSK1 PCSK5 PCSK6	4.22e-06	6	209	3	9291583
Pubmed	ABCE1 is a highly conserved RNA silencing suppressor.	HEXB CIAO1 GNA11 GNAQ MED23 FLNA GSPT1 IGF2R PEBP1	4.42e-06	204	209	9	25659154
Pubmed	Proteolytic processing in the secretory pathway.	PCSK1 PCSK5 PCSK6	7.36e-06	7	209	3	10409610
Pubmed	The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions.	PCSK1 PCSK5 PCSK6	7.36e-06	7	209	3	7819324
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	TRIM26 EML2 CEPT1 NEU2 KIDINS220 PI4KA YTHDF2 PRSS12 TUT7 LAMA3 IDH1 PRDX6 GSTP1 LIG3 PTCD1 PEBP1	1.03e-05	732	209	16	34732716
Pubmed	Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases.	PCSK1 PCSK5 PCSK6	1.17e-05	8	209	3	9885250
Pubmed	Cellular localization and role of prohormone convertases in the processing of pro-melanin concentrating hormone in mammals.	PCSK1 PCSK5 PCSK6	1.17e-05	8	209	3	10037747
Pubmed	The biology and therapeutic targeting of the proprotein convertases.	PCSK1 PCSK5 PCSK6	1.75e-05	9	209	3	22679642
Pubmed	A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.	GNA11 GNAQ CD22	1.75e-05	9	209	3	10829070
Pubmed	The prohormone theory and the proprotein convertases: it is all about serendipity.	PCSK1 PCSK5 PCSK6	1.75e-05	9	209	3	21805236
Pubmed	The proprotein convertases, 20 years later.	PCSK1 PCSK5 PCSK6	1.75e-05	9	209	3	21805237
Pubmed	The activation and physiological functions of the proprotein convertases.	PCSK1 PCSK5 PCSK6	1.75e-05	9	209	3	18343183
Pubmed	Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.	C6 CR1 CR1L	1.75e-05	9	209	3	18947875
Pubmed	The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions.	PCSK1 PCSK5 PCSK6	1.75e-05	9	209	3	23775089
Pubmed	SPC4, SPC6, and the novel protease SPC7 are coexpressed with bone morphogenetic proteins at distinct sites during embryogenesis.	PCSK1 PCSK5 PCSK6	1.75e-05	9	209	3	8698813
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MECOM CHD1 EDDM3A NUP205 GMPS CEPT1 PTPRA UBE3A MIB1 ASPM ALG8 OBI1 YTHDF2 MAPKAP1 PARP11 FLNA MORC2 NBAS CSK CFAP97D1 GATAD1 SLFN11	1.83e-05	1327	209	22	32694731
Pubmed	Expression and transient nuclear translocation of proprotein convertase 1 (PC1) during mouse preimplantation embryonic development.	PCSK1 PCSK5 PCSK6	2.49e-05	10	209	3	16163737
Pubmed	IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?	IDH1 IDH2	3.59e-05	2	209	2	30176240
Pubmed	Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.	IDH1 IDH2	3.59e-05	2	209	2	34078652
Pubmed	Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.	ALCAM CD6	3.59e-05	2	209	2	16818773
Pubmed	High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.	IDH1 IDH2	3.59e-05	2	209	2	21480859
Pubmed	Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens.	ALCAM CD6	3.59e-05	2	209	2	16818742
Pubmed	Functional identification of transcription control sequences of the mouse Crry gene.	CR1 CR1L	3.59e-05	2	209	2	8335915
Pubmed	The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.	GNA11 GNAQ	3.59e-05	2	209	2	28248732
Pubmed	Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.	IDH1 IDH2	3.59e-05	2	209	2	23391413
Pubmed	Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.	IDH1 IDH2	3.59e-05	2	209	2	29126125
Pubmed	Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.	IDH1 IDH2	3.59e-05	2	209	2	20142433
Pubmed	Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells.	CR1 CR1L	3.59e-05	2	209	2	10779754
Pubmed	Insular primary glioblastomas with IDH mutations: Clinical and biological specificities.	IDH1 IDH2	3.59e-05	2	209	2	28116838
Pubmed	Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.	IDH1 IDH2	3.59e-05	2	209	2	20538800
Pubmed	IDH mutations in older patients with diffuse astrocytic gliomas.	IDH1 IDH2	3.59e-05	2	209	2	33137656
Pubmed	Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.	IDH1 IDH2	3.59e-05	2	209	2	25783747
Pubmed	Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.	CR1 CR1L	3.59e-05	2	209	2	16444293
Pubmed	Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma.	IDH1 IDH2	3.59e-05	2	209	2	31609487
Pubmed	Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.	IDH1 IDH2	3.59e-05	2	209	2	32027343
Pubmed	IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management.	IDH1 IDH2	3.59e-05	2	209	2	31876581
Pubmed	Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.	IDH1 IDH2	3.59e-05	2	209	2	22136423
Pubmed	Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.	IDH1 IDH2	3.59e-05	2	209	2	32382048
Pubmed	Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience.	IDH1 IDH2	3.59e-05	2	209	2	34162262
Pubmed	Receptor-like protein-tyrosine phosphatase α enhances cell surface expression of neural adhesion molecule NB-3.	CNTN6 PTPRA	3.59e-05	2	209	2	21622556
Pubmed	Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.	IDH1 IDH2	3.59e-05	2	209	2	28297679
Pubmed	Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.	GSPT2 GSPT1	3.59e-05	2	209	2	15987998
Pubmed	Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target.	IDH1 IDH2	3.59e-05	2	209	2	22002076
Pubmed	[IDH1- and IDH2-mutations in brain glial tumors - the new antioncogenic mechanism].	IDH1 IDH2	3.59e-05	2	209	2	29863707
Pubmed	Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q).	IDH1 IDH2	3.59e-05	2	209	2	31685963
Pubmed	Polymorphisms in the CD6-ALCAM axis may modulate psoriasis risk and outcomes.	ALCAM CD6	3.59e-05	2	209	2	38580538
Pubmed	Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer.	IDH1 IDH2	3.59e-05	2	209	2	31068457
Pubmed	IDH mutations occur frequently in Chinese glioma patients and predict longer survival but not response to concomitant chemoradiotherapy in anaplastic gliomas.	IDH1 IDH2	3.59e-05	2	209	2	21874255
Pubmed	Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.	IDH1 IDH2	3.59e-05	2	209	2	22427879
Pubmed	Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.	IDH1 IDH2	3.59e-05	2	209	2	21996744
Pubmed	Induction of direct antimicrobial activity through mammalian toll-like receptors.	MRC1 TLR2	3.59e-05	2	209	2	11222859
Pubmed	Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma.	IDH1 IDH2	3.59e-05	2	209	2	38842680
Pubmed	Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens.	GNA11 GNAQ	3.59e-05	2	209	2	21945171
Pubmed	A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders.	IDH1 IDH2	3.59e-05	2	209	2	20962861
Pubmed	Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.	IDH1 IDH2	3.59e-05	2	209	2	28552826
Pubmed	The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.	IDH1 IDH2	3.59e-05	2	209	2	26046462
Pubmed	Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors.	IDH1 IDH2	3.59e-05	2	209	2	23232569
Pubmed	Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.	IDH1 IDH2	3.59e-05	2	209	2	23641016
Pubmed	Distinct IDH1/IDH2 mutation profiles in purely insular versus paralimbic WHO Grade II gliomas.	IDH1 IDH2	3.59e-05	2	209	2	23330999
Pubmed	IDH1/2 Mutations in Cancer Stem Cells and Their Implications for Differentiation Therapy.	IDH1 IDH2	3.59e-05	2	209	2	34967233
Pubmed	IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution.	IDH1 IDH2	3.59e-05	2	209	2	32333643
Pubmed	Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation.	IDH1 IDH2	3.59e-05	2	209	2	27431380
Pubmed	Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma.	IDH1 IDH2	3.59e-05	2	209	2	24569570
Pubmed	Isocitrate dehydrogenase 1/2 mutational analyses and 2-hydroxyglutarate measurements in Wilms tumors.	IDH1 IDH2	3.59e-05	2	209	2	21225914
Pubmed	Cancer-associated IDH mutations: biomarker and therapeutic opportunities.	IDH1 IDH2	3.59e-05	2	209	2	20972461
Pubmed	Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.	IDH1 IDH2	3.59e-05	2	209	2	24460285
Pubmed	2-hydroxyglutarate accumulation caused by IDH mutation is involved in the formation of malignant gliomas.	IDH1 IDH2	3.59e-05	2	209	2	20367200
Pubmed	Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas.	IDH1 IDH2	3.59e-05	2	209	2	35996504
Pubmed	Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer.	IDH1 IDH2	3.59e-05	2	209	2	26819452
Pubmed	Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders.	IDH1 IDH2	3.59e-05	2	209	2	25486927
Pubmed	Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia.	IDH1 IDH2	3.59e-05	2	209	2	25651001
Pubmed	Phospholipase A2 Group III and Group X Have Opposing Associations with Prognosis in Colorectal Cancer.	PLA2G10 PLA2G3	3.59e-05	2	209	2	25964585
Pubmed	Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.	IDH1 IDH2	3.59e-05	2	209	2	30355724
Pubmed	Molecular classification of low-grade diffuse gliomas.	IDH1 IDH2	3.59e-05	2	209	2	21075857
Pubmed	Gonadotropin and gonadal steroid release in response to a gonadotropin-releasing hormone agonist in Gqalpha and G11alpha knockout mice.	GNA11 GNAQ	3.59e-05	2	209	2	9607776
Pubmed	IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.	IDH1 IDH2	3.59e-05	2	209	2	26158269
Pubmed	Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.	IDH1 IDH2	3.59e-05	2	209	2	33740099
Pubmed	Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML.	IDH1 IDH2	3.59e-05	2	209	2	26016821
Pubmed	IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment.	IDH1 IDH2	3.59e-05	2	209	2	34095989
Pubmed	Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.	GNA11 GNAQ	3.59e-05	2	209	2	26628681
Pubmed	Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.	ALCAM CD6	3.59e-05	2	209	2	26146185
Pubmed	The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia.	IDH1 IDH2	3.59e-05	2	209	2	29090344
Pubmed	IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom.	IDH1 IDH2	3.59e-05	2	209	2	22217666
Pubmed	Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.	IDH1 IDH2	3.59e-05	2	209	2	30115812
Pubmed	Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.	IDH1 IDH2	3.59e-05	2	209	2	28340142
Pubmed	The time-course of agonist-induced solubilization of trimeric G(q)alpha/G(11)alpha proteins resolved by two-dimensional electrophoresis.	GNA11 GNAQ	3.59e-05	2	209	2	17552882
Pubmed	Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.	IDH1 IDH2	3.59e-05	2	209	2	22616558
Pubmed	Latrophilin GPCR signaling mediates synapse formation.	ADGRL2 ADGRL3	3.59e-05	2	209	2	33646123
Pubmed	Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.	GNA11 GNAQ	3.59e-05	2	209	2	29209985
Pubmed	The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.	CR1 CR1L	3.59e-05	2	209	2	12767833
Pubmed	CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.	ALCAM CD6	3.59e-05	2	209	2	9436462
Pubmed	[Coexisting Mutations in IDH1/2-Mutated Acute Myeloid Leukemia].	IDH1 IDH2	3.59e-05	2	209	2	31607296
Pubmed	Dual compartmental localization and function of mammalian NADP+-specific isocitrate dehydrogenase in yeast.	IDH1 IDH2	3.59e-05	2	209	2	18275837
Pubmed	IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors.	IDH1 IDH2	3.59e-05	2	209	2	29339439
Cytoband	5q15-q21	PCSK1 CHD1	2.06e-05	2	209	2	5q15-q21
GeneFamily	Immunoglobulin like domain containing	CEACAM1 FCER1A HMCN2 ALCAM IGSF3 FCRL6 CNTN3 MYOM2 CEACAM20	3.22e-05	193	149	9	594
GeneFamily	C-type lectin domain family	CLEC19A MRC1 CLEC9A ASGR1 LY75	4.12e-05	47	149	5	494
GeneFamily	Proprotein convertase subtilisin/kexin family	PCSK1 PCSK5 PCSK6	4.44e-05	9	149	3	973
GeneFamily	Fibronectin type III domain containing	EPHB6 NCAM2 CNTN6 PTPRH CNTN3 ASTN1 MYOM2 ANKFN1	5.47e-05	160	149	8	555
GeneFamily	Sulfotransferases, cytosolic	SULT1C4 SULT2A1 SULT6B1	1.87e-04	14	149	3	762
GeneFamily	Zinc fingers C2H2C-type	MYT1L ST18	2.01e-04	3	149	2	1261
GeneFamily	WD repeat domain containing	EML2 DDB2 WDR3 EML5 CIAO1 FBXW5 WDR88 PPWD1 MAPKBP1	3.28e-04	262	149	9	362
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NCAM2 CNTN6 HMCN2 HMCN1 CNTN3 MYOM2 CEACAM20	3.80e-04	161	149	7	593
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL2 ADGRL3	4.00e-04	4	149	2	918
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRA PTPRH PTPRN	6.54e-04	21	149	3	813
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CEACAM1 ALCAM MRC1 CLEC9A CR1 IGF2R CD6 CD22 TLR2 LY75	1.61e-03	394	149	10	471
GeneFamily	Fibulins	HMCN2 HMCN1	1.83e-03	8	149	2	556
GeneFamily	Complement system\|Sushi domain containing	C6 CR1 CR1L	3.21e-03	36	149	3	492
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	ALCAM CD200R1 CD22	4.34e-03	40	149	3	592
GeneFamily	Phospholipases	PLA2G10 PLA2G3 PLA2G4C	4.98e-03	42	149	3	467
GeneFamily	Forkhead boxes	FOXJ2 FOXN3 FOXL2	5.32e-03	43	149	3	508
GeneFamily	Collagens	COL24A1 COL3A1 COL5A2	6.43e-03	46	149	3	490
Coexpression	MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	PCSK5 TYRP1 CTHRC1 COL3A1 COL5A2 IGF2BP3 HMCN1	7.67e-06	90	208	7	M38984
Coexpression	DESCARTES_FETAL_MUSCLE_MYELOID_CELLS	BLNK CR1 CD200R1 TLR2 LY75 FAM20A ST18 ADAP2	9.75e-06	130	208	8	M40259
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	NEK6 TRIM26 CHD1 FANCC FZD1 ALCAM ADGRL2 TUT7 SAMHD1 GSPT1 ADGRG6 SLFN11 MAPKBP1 ADAP2	1.10e-05	435	208	14	MM1221
Coexpression	VANHARANTA_UTERINE_FIBROID_UP	STARD13 DDB2 IGSF3 COL3A1 COL5A2	2.53e-05	44	208	5	M18274
Coexpression	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	ASPM CTHRC1 COL3A1 COL5A2 DDX60 NBAS	2.75e-05	74	208	6	M4479
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE	PCSK5 PRDM1 FZD1 CTHRC1 POPDC3 COL5A2 TLR2 LY75 FAM20A	3.09e-05	198	208	9	MM17083
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	NEK6 TRIM26 CHD1 FANCC FZD1 ALCAM ADGRL2 TUT7 SAMHD1 GSPT1 ADGRG6 MAPKBP1 ADAP2	3.24e-05	418	208	13	M12676
Coexpression	SANSOM_APC_TARGETS_DN	MYT1L PCSK5 MEP1B GNA11 DPEP1 ERO1B ZAP70 CD6 PLPP1 CD22 REG3A LY75	3.93e-05	366	208	12	M1432
Coexpression	DESCARTES_FETAL_INTESTINE_ENS_NEURONS	MYT1L NCAM2 GCGR EML5 CRABP1 TAGLN3 ASTN1 KCNH5	4.57e-05	161	208	8	M40214
Coexpression	ZHENG_BOUND_BY_FOXP3	CHD2 PRDM1 RABGAP1L SUMF1 OBI1 PARP11 SAMHD1 IDH1 CR1 CR1L ZAP70 CD200R1 MRPL39 ZBTB25	5.86e-05	507	208	14	MM1030
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL	ALCAM COL3A1 CHODL ADGRG6 HMCN1 TSLP	6.03e-05	85	208	6	M45761
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TXK COL24A1 COL5A2 DDX60 PLA2G3 CUBN ADGRG6 SEMA3D ASGR1 PCSK6	7.92e-09	169	209	10	d0c64ca31053dfc283a07d5ad1117ca7dc1777a7
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TXK COL24A1 COL5A2 DDX60 PLA2G3 CUBN ADGRG6 SEMA3D ASGR1 PCSK6	7.92e-09	169	209	10	d79abfbeffd082a4fbffbc1051ffc474374874fa
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 TMPRSS15 FOXN3 F11 MEP1B SULT2A1 DPEP1 RESF1 PEBP1 REG3A	1.98e-08	186	209	10	bdd9d3a432aab46e733469b362f0064d35c1ac49
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 TMPRSS15 FOXN3 F11 MEP1B SULT2A1 DPEP1 RESF1 PEBP1 REG3A	2.08e-08	187	209	10	9042bd0f57213a51503d9df2e4dce3209b7772d3
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HEXB NEK6 ALCAM MRC1 CAMK1 ASGR1 TLR2 SLFN11 FAM20A ADAP2	2.81e-08	193	209	10	93ba635ed69fec9286fe7636b9d258f3d93a22c3
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HEXB NEK6 ALCAM MRC1 CAMK1 ASGR1 TLR2 SLFN11 FAM20A ADAP2	2.81e-08	193	209	10	6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LDLRAD1 ANKUB1 C6 PRSS12 ECT2L TMEM232 CNTN3 ANKFN1 CFAP46	1.82e-07	179	209	9	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 NCAM2 ADGRV1 COL24A1 ADGRL3 HMCN1 GUCY2F MYOM2 ST18	2.30e-07	184	209	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	3'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 TMPRSS15 F11 MEP1B SULT2A1 DPEP1 RESF1 PEBP1 REG3A	2.30e-07	184	209	9	ed7a8e79e5723a5f5a03f542203d9e50bdef5f50
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 NCAM2 ADGRV1 COL24A1 ADGRL3 HMCN1 GUCY2F MYOM2 ST18	2.30e-07	184	209	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 NCAM2 ADGRV1 COL24A1 ADGRL3 HMCN1 GUCY2F MYOM2 ST18	2.30e-07	184	209	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRRK2 MRC1 KCNK13 SAMHD1 CR1 CD200R1 TLR2 SLFN11 ADAP2	3.44e-07	193	209	9	c9e3fefa8d68d0e2b954f85ce37813185ff98d84
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HEXB ALCAM MRC1 CAMK1 ASGR1 TLR2 SLFN11 FAM20A ADAP2	3.59e-07	194	209	9	e455cb469157c044126f9b0b308957d4ee1e608b
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HEXB ALCAM MRC1 CAMK1 ASGR1 TLR2 SLFN11 FAM20A ADAP2	3.59e-07	194	209	9	e0cfd18a7ea2251163d61312b9397f8a518c8c51
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FOXN3 MRC1 SAMHD1 CR1 ZAP70 CD200R1 CD6 TLR2 ADAP2	3.75e-07	195	209	9	2d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCell	Mild_COVID-19-Myeloid-MoAM3\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	HEXB ALCAM MRC1 CAMK1 ASGR1 TLR2 SLFN11 FAM20A ADAP2	3.91e-07	196	209	9	9faad17aa0b6af5a8ec2dadf7d70b9209d658072
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	LRRK2 ADGRB3 COL3A1 COL5A2 LAMA3 IDH1 SEMA3D PLA2G4C PLPP1	4.08e-07	197	209	9	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	(0)_NK_FCGR3Apos\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PCSK5 TXK PRDM1 GNAQ FLNA ZAP70 FCRL6 IGF2R MYOM2	4.26e-07	198	209	9	13f10f9233fc1523f0da2d9d59f3ced9c51a603a
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 BLNK MRC1 IDH1 CR1 IGF2R CSK ASGR1 NEURL1	4.44e-07	199	209	9	4e0b73d88b1345ec63a9e5629762341e75beb47f
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	MYT1L NCAM2 GPR158 GPC5 ADGRL3 GRM5 ANKFN1 KCNH5	8.81e-07	159	209	8	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L3-5_FEZF2_DCN\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TXK COL5A2 DDX60 ADGRG6 OR51S1 SEMA3D ASGR1 PCSK6	1.17e-06	165	209	8	aad0ab96d9d4387edfcef2b114346a030eb4b021
ToppCell	facs-Lung-EPCAM-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BLNK TYRP1 FOXL2 RABGAP1L PPWD1 CD22 CSK CFAP97D1	1.33e-06	168	209	8	784ce773521e5d74570f45120e56d112bc76ff49
ToppCell	facs-Lung-EPCAM-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BLNK TYRP1 FOXL2 RABGAP1L PPWD1 CD22 CSK CFAP97D1	1.46e-06	170	209	8	7a4ed69c807c3761210776e8fe6680d1bd892e82
ToppCell	Club_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	PARP11 MYO18A CUBN L3MBTL1 HMCN1 CNTN3 ANKFN1	1.61e-06	120	209	7	7f85208f0455f3e634f8e7e81beea60b4ef1d2a5
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 CEACAM1 MEP1B PTPRH PLEKHA8 DPEP1 MYO18A CEACAM20	1.89e-06	176	209	8	7622f5a8e7320cc7b593141854107ecaf4adff7f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB6 NCAM2 CNTN6 COL24A1 ASPM ADGRL2 COL5A2 MYOM2	2.63e-06	184	209	8	ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL3A1 DPEP1 COL5A2 CHODL SEMA3D HMCN1 FAM20A TSLP	2.74e-06	185	209	8	c85bba1210f1d389add3e40be9b96abac40cf8c1
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDLRAD1 FZD1 GSPT2 IGSF3 COL3A1 DPEP1 COL5A2 PCSK6	2.85e-06	186	209	8	35c88cc4eb388811fcac4323b549e5897fa8dc27
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB6 NCAM2 CNTN6 COL24A1 ASPM ADGRL2 COL5A2 MYOM2	2.85e-06	186	209	8	77b09af860183606a1775eba921e2071e4a7dd4e
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 MECOM POMT2 COL5A2 LAMA3 ADGRG6 OLFM2 FAM20A	2.85e-06	186	209	8	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDLRAD1 FZD1 GSPT2 IGSF3 COL3A1 DPEP1 COL5A2 PCSK6	2.85e-06	186	209	8	d998c5b00083cf2a7cd5341a98b7374b4de73c63
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKUB1 FCER1A MRC1 CLEC9A KCNK13 CD200R1 ADAP2	3.04e-06	132	209	7	f8e2ba53063007d7507f1837ad669b0e4333cd23
ToppCell	facs-Aorta-Heart-3m-Endothelial-coronary_vascular_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFSD4B ADGRL3 PARP11 L3MBTL1 ST18 CEACAM20 KCNH5	3.04e-06	132	209	7	dc13b54e38fbda9341972cef11833041f2f2a345
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BLNK PRDM1 MRC1 KCNK13 SAMHD1 CD200R1 SLFN11 ADAP2	3.09e-06	188	209	8	f4d11d06be46f13adbf36d94bc2bdcd14d0bfa75
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRDM1 MRC1 KCNK13 CR1 CD200R1 SLFN11 FAM20A ADAP2	3.34e-06	190	209	8	773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADGRB3 MECOM NCAM2 ADGRL3 COL3A1 COL5A2 PCSK6 UGGT2	3.47e-06	191	209	8	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LDLRAD1 C6 CLEC19A PRSS12 ECT2L TMEM232 ANKFN1 CFAP46	3.47e-06	191	209	8	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LDLRAD1 C6 CLEC19A PRSS12 ECT2L TMEM232 ANKFN1 CFAP46	3.47e-06	191	209	8	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ADGRB3 MECOM NCAM2 ADGRL3 COL3A1 COL5A2 PCSK6 UGGT2	3.47e-06	191	209	8	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LDLRAD1 C6 CLEC19A PRSS12 ECT2L TMEM232 ANKFN1 CFAP46	3.47e-06	191	209	8	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L TMPRSS15 EML5 CHODL CRABP1 TAGLN3 ST18 KCNH5	3.61e-06	192	209	8	d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	LDLRAD1 C6 CLEC19A PRSS12 ECT2L TMEM232 ANKFN1 CFAP46	3.61e-06	192	209	8	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	ADGRB3 MECOM NCAM2 COL24A1 COL3A1 COL5A2 SAMHD1 UGGT2	3.61e-06	192	209	8	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L TMPRSS15 EML5 CHODL CRABP1 TAGLN3 ST18 KCNH5	3.75e-06	193	209	8	9661ea0ee7273928c7de2a9f49e853595fa77699
ToppCell	control-Myeloid-mDC\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FCER1A ALCAM MRC1 SAMHD1 CD200R1 ADGRG6 GSTP1 PEBP1	3.75e-06	193	209	8	5e43024763932a679c33d83cf8f606612bc0f600
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	ADGRB3 MECOM NCAM2 ADGRL3 COL3A1 COL5A2 SAMHD1 UGGT2	3.89e-06	194	209	8	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRDM1 MRC1 KCNK13 CR1 CD200R1 TLR2 FAM20A ADAP2	3.89e-06	194	209	8	a062100ea6cd512a108f9036c259e0cd0f458563
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	STARD13 ANKUB1 ALCAM GNAQ MRC1 CR1 TLR2 ADAP2	4.04e-06	195	209	8	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADGRB3 MECOM NCAM2 ADGRL3 COL3A1 COL5A2 PCSK6 UGGT2	4.04e-06	195	209	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 FZD1 COL24A1 ADGRL2 COL3A1 COL5A2 ADGRG6 SEMA3D	4.04e-06	195	209	8	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PCSK5 ADGRB3 NCAM2 HMCN2 COL3A1 COL5A2 PCSK6 UGGT2	4.04e-06	195	209	8	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L TMPRSS15 EML5 CHODL CRABP1 TAGLN3 ST18 KCNH5	4.04e-06	195	209	8	b25c534fc6320d4da6437ef1b27e32a5d5256f3e
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRDM1 MRC1 CR1 CD200R1 TLR2 SLFN11 FAM20A ADAP2	4.04e-06	195	209	8	028622b234551b185977fbee10c06851a45456a5
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PRDM1 FANCC PI4KA PRSS12 ZAP70 CD6	4.09e-06	138	209	7	19ffd66256fa94d728138d37d0a5a3bac7722dbb
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PRDM1 FANCC PI4KA PRSS12 ZAP70 CD6	4.09e-06	138	209	7	321070b6900887b27da0f2b25808a05a8ab89ee7
ToppCell	(0)_Myeloid-(010)_cDC\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	BLNK FCER1A ALCAM MRC1 CLEC9A FCRL6 CD200R1 PEBP1	4.20e-06	196	209	8	ea8cf29a9d4d177d092b0568fd4601cd7f906884
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L TMPRSS15 EML5 CHODL CRABP1 TAGLN3 ST18 KCNH5	4.36e-06	197	209	8	8951787ed1f7ac1772a6ef0ba2dd44c51fd3c47b
ToppCell	mild_COVID-19-cDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	HEXB FCER1A ALCAM MRC1 CLEC9A KCNK13 ADGRG6 ST18	4.36e-06	197	209	8	44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 COL24A1 ADGRL2 COL3A1 COL5A2 ADGRG6 SEMA3D PLPP1	4.36e-06	197	209	8	31a1852911bda38543916585fda34255fd62a134
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	NEK6 NCAM2 FOXN3 COL24A1 CTHRC1 COL3A1 COL5A2 HMCN1	4.36e-06	197	209	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	5'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 TMPRSS15 MEP1B SULT2A1 GNA11 DPEP1 PEBP1 REG3A	4.53e-06	198	209	8	8d629492d2199de8e036c19e9dacceb9c9e721a0
ToppCell	metastatic_Lymph_Node-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	PCSK5 TXK FLNA ZAP70 FCRL6 GSTP1 IGF2R MYOM2	4.53e-06	198	209	8	cc4c1306683b801c1cb0adc01951aa6e3d73626f
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MECOM ADGRV1 GPC5 ALCAM LAMA3 TMEM87A LRP6 FAM20A	4.70e-06	199	209	8	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 MECOM ADGRV1 GPC5 ALCAM LAMA3 TMEM87A FAM20A	4.70e-06	199	209	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 TMPRSS15 MEP1B SULT2A1 GNA11 DPEP1 PEBP1 REG3A	4.70e-06	199	209	8	01c2721bc82cd672e9477029b4a7ecc77e2f1b00
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PCSK5 ALCAM COL3A1 COL5A2 FLNA PRSS12 ADGRG6 SEMA3D	4.87e-06	200	209	8	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GCNT3 ADGRB3 ADGRV1 CEACAM1 ADGRG6 LRP6 ASTN1 FAM20A	4.87e-06	200	209	8	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GSPT2 PI4KA C6 TARS1 ADGRL3 PLA2G4C ZBTB25	5.41e-06	144	209	7	1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIDINS220 TMEM145 C6 DNMT3B USP49 THEM5 CAMK1	5.93e-06	146	209	7	447c05414eda71681a0c07baba900f88ed6165ed
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYT1L PCSK1 PTPRH PTPRN TMEM145 TAGLN3 ST18	1.04e-05	159	209	7	7747cef94c55144fddcd024a7495318357f1351b
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_4\|343B / Donor, Lineage, Cell class and subclass (all cells)	HEXB NEK6 USP49 MRC1 SAMHD1 ASGR1 SLFN11	1.12e-05	161	209	7	5cd483b73bcb3615ea56eb81c1c293e61b84b66d
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK1 ANKUB1 ADGRV1 CNTN6 GUCY2F CNTN3 ST18	1.17e-05	162	209	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Mild-Lymphoid-NK-innate_T\|Mild / Condition, Lineage, Cell class and cell subclass	FOXJ2 TXK NMT2 IPPK USP49 TMEM182 OLFM2	1.17e-05	162	209	7	bd218e41b2eadc3bba4c7ac3e34a014f6ad8b1bf
ToppCell	droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BLNK MRC1 KCNK13 CAMK1 TAGLN3 ST18 ADAP2	1.32e-05	165	209	7	6dda1c7fd812792bd2e4fb1a7ccb82a3552b0a3b
ToppCell	droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRDM1 ARFGAP3 ALCAM ADGRL2 ERO1B CUBN ASTN1	1.32e-05	165	209	7	21a82a975f550080b6674750b06212205cd16742
ToppCell	RA-01._Fibroblast_I\|RA / Chamber and Cluster_Paper	ADGRB3 MECOM NCAM2 COL24A1 COL5A2 SAMHD1 UGGT2	1.54e-05	169	209	7	6373562ab3b1765060212a6a53d6543e7e942e80
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L ADGRV1 CNTN6 COL24A1 C6 CUBN PLA2G4C	1.54e-05	169	209	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	MECOM ADGRV1 CNTN6 GPC5 ALCAM ADGRL2 LAMA3	1.60e-05	170	209	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 FCER1A EML5 PARP11 CD200R1 ZFAND1 KCTD18	1.79e-05	173	209	7	4c788c1dad1da495b3b5c10f95e779848dfe85dc
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK1 FCER1A EML5 PARP11 CD200R1 ZFAND1 KCTD18	1.79e-05	173	209	7	6e92983d9f8a2a37f23e60a0d5bb1738217897bc
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L PCSK1 ADGRB3 HMCN2 PTPRN PLEKHA8 TAGLN3	1.86e-05	174	209	7	742c73c9e090848b464323cb17579b86658c6792
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEACAM1 MEP1B PTPRH PLEKHA8 DPEP1 PRDX6 CEACAM20	1.86e-05	174	209	7	7c52b5d8f1e65e5208c952be341fa155ed0e6e76
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEACAM1 MEP1B PTPRH PLEKHA8 DPEP1 PRDX6 CEACAM20	1.86e-05	174	209	7	2fbdb62e269acf4447b171700a615e878dde7f9f
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L PCSK1 ADGRB3 HMCN2 PTPRN PLEKHA8 TAGLN3	1.86e-05	174	209	7	7fed9722e64c60843092f2ba71256e3043011ef6
ToppCell	10x5'-blood-Myeloid_Dendritic\|blood / Manually curated celltypes from each tissue	BLNK FCER1A MRC1 CLEC9A ADGRG6 GSTP1 ST18	1.93e-05	175	209	7	1c48eec300d5a6d4a810947b995af3b8c0a5a601
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM GPC5 ADGRL2 IDH2 CRABP1 HMCN1 PEBP1	1.93e-05	175	209	7	787ac1a12cda10af5c8830471702a4cbaf43e79e
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L NCAM2 GCGR EML5 CRABP1 TAGLN3 ST18	2.00e-05	176	209	7	116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYT1L NCAM2 GCGR EML5 CRABP1 TAGLN3 ST18	2.00e-05	176	209	7	5b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-B_cell-B_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BLNK TMEM182 ERO1B THEM5 CD22 CSK CEACAM20	2.00e-05	176	209	7	27c132e9852717cbc345af7a1fc390e9ea589416
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-B_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BLNK TMEM182 ERO1B THEM5 CD22 CSK CEACAM20	2.00e-05	176	209	7	259d1864fb0a6d2feddc90bc715e2bccbb373792
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ALCAM COL3A1 COL5A2 CRABP1 SEMA3D ASTN1 OLFM2	2.07e-05	177	209	7	7af1a19692f7fe8f691178a4e57d62bc379e3d56
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BLNK MECOM GPC5 IGSF3 IDH2 CRABP1 PEBP1	2.07e-05	177	209	7	dc846d0feb94d4c289553cc3ac9dac81d10409cb
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LDLRAD1 C6 CLEC19A ECT2L TMEM232 ANKFN1 CFAP46	2.15e-05	178	209	7	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK1 PTPRN GPC5 DPEP1 ASGR1 NEURL1 ST18	2.39e-05	181	209	7	cb17c904ab86d56dd30cac9b61acbb3b76f84ded
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	FCER1A MRC1 KCNK13 SAMHD1 ASGR1 TLR2 ADAP2	2.39e-05	181	209	7	921e917f83105896ad8918dc134b871708024021
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	LDLRAD1 C6 CLEC19A ECT2L TMEM232 ANKFN1 CFAP46	2.48e-05	182	209	7	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	LDLRAD1 C6 ECT2L GRM5 TMEM232 ANKFN1 CFAP46	2.48e-05	182	209	7	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LDLRAD1 FZD1 GSPT2 IGSF3 COL3A1 DPEP1 COL5A2	2.48e-05	182	209	7	f4b74c2756989812abe4e7055ec8918f69d56025
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 MECOM CTHRC1 COL5A2 LAMA3 ADGRG6 OLFM2	2.48e-05	182	209	7	c7f2d24697affa530b748ab32b1d40bdc1bdc20a
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 MECOM CTHRC1 COL5A2 LAMA3 ADGRG6 OLFM2	2.48e-05	182	209	7	d95635b74e8cd8bc00bfe40340806b59fb9bee43
Drug	Nadolol [42200-33-9]; Down 200; 13uM; PC3; HT_HG-U133A	TTLL5 FRS3 FOXN3 TXK FANCC SLC22A14 ADGRL3 DEAF1 ERO1B LIG3 L3MBTL1 ASTN1	3.00e-07	198	208	12	4021_DN
Drug	DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A	PCSK1 KLHL24 FOXN3 PRDM1 SLC22A14 COL3A1 CHODL PLA2G3 L3MBTL1 PLA2G4C PCSK6	2.01e-06	196	208	11	2877_UP
Drug	Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A	PCSK5 TTLL5 MECOM FOXL2 KPNA5 COL5A2 CD6 LRRC31 TLR2 TAGLN3 NEURL1	2.44e-06	200	208	11	3167_UP
Disease	oligodendroglioma	POT1 IDH1 IDH2	1.80e-05	8	205	3	C0028945
Disease	Anaplastic Oligodendroglioma	POT1 IDH1 IDH2	1.80e-05	8	205	3	C0334590
Disease	acute myeloid leukemia (is_implicated_in)	FANCC DNMT3B SAMHD1 IDH1 IDH2 GSTP1	2.71e-05	84	205	6	DOID:9119 (is_implicated_in)
Disease	hepatocellular clear cell carcinoma (is_implicated_in)	IDH1 IDH2	4.80e-05	2	205	2	DOID:5016 (is_implicated_in)
Disease	Chondroma	IDH1 IDH2	4.80e-05	2	205	2	C0936248
Disease	Enchondroma	IDH1 IDH2	4.80e-05	2	205	2	C1704356
Disease	Phakomatosis cesioflammea	GNA11 GNAQ	4.80e-05	2	205	2	C3838883
Disease	Congenital hemangioma	GNA11 GNAQ	4.80e-05	2	205	2	C0235753
Disease	Port-wine stain with oculocutaneous melanosis	GNA11 GNAQ	4.80e-05	2	205	2	C1274879
Disease	FANCONI ANEMIA, COMPLEMENTATION GROUP C	FANCC FANCB	4.80e-05	2	205	2	C3468041
Disease	Maffucci Syndrome	IDH1 IDH2	1.43e-04	3	205	2	C0024454
Disease	Enchondromatosis	IDH1 IDH2	2.86e-04	4	205	2	C0014084
Disease	Hemangioma, Intramuscular	IDH1 IDH2	2.86e-04	4	205	2	C0205789
Disease	Histiocytoid hemangioma	IDH1 IDH2	2.86e-04	4	205	2	C0205788
Disease	Chorioangioma	IDH1 IDH2	2.86e-04	4	205	2	C0677608
Disease	Angioma	IDH1 IDH2	2.86e-04	4	205	2	C1959588
Disease	Hemangioma	IDH1 IDH2	2.86e-04	4	205	2	C0018916
Disease	Dyschondroplasias	FLNA IDH1 IDH2	2.95e-04	19	205	3	C0013366
Disease	Malignant melanoma of iris	GNA11 GNAQ	4.74e-04	5	205	2	C0346373
Disease	Malignant melanoma of choroid	GNA11 GNAQ	4.74e-04	5	205	2	C0346388
Disease	autosomal recessive limb-girdle muscular dystrophy (is_implicated_in)	POPDC3 POMT2	4.74e-04	5	205	2	DOID:0110274 (is_implicated_in)
Disease	Immunologic Deficiency Syndromes	DNMT3B ZAP70 NBAS	5.28e-04	23	205	3	C0021051
Disease	Albuminuria	GPC5 GNAQ TSLP	6.01e-04	24	205	3	C0001925
Disease	Biliary Tract Neoplasm	IDH1 IDH2	7.07e-04	6	205	2	C0005426
Disease	regenerating islet-derived protein 3-alpha measurement	PRDM1 REG3A	7.07e-04	6	205	2	EFO_0803004
Disease	spinal muscular atrophy (is_implicated_in)	HEXB SMN1	7.07e-04	6	205	2	DOID:12377 (is_implicated_in)
Disease	Pancytopenia	MECOM FANCC FANCB	7.64e-04	26	205	3	C0030312
Disease	Endogenous Hyperinsulinism	FANCC COL3A1 MRC1	7.64e-04	26	205	3	C1257963
Disease	Exogenous Hyperinsulinism	FANCC COL3A1 MRC1	7.64e-04	26	205	3	C1257964
Disease	Compensatory Hyperinsulinemia	FANCC COL3A1 MRC1	7.64e-04	26	205	3	C1257965
Disease	Hyperinsulinism	FANCC COL3A1 MRC1	9.52e-04	28	205	3	C0020459
Disease	Childhood Oligodendroglioma	IDH1 IDH2	9.86e-04	7	205	2	C0280475
Disease	blood sedimentation	CR1 CR1L	9.86e-04	7	205	2	EFO_0004304
Disease	Adult Oligodendroglioma	IDH1 IDH2	9.86e-04	7	205	2	C0279070
Disease	calcineurin subunit B type 1 measurement	C6 PCSK6	9.86e-04	7	205	2	EFO_0020215
Disease	Oligodendroblastoma	IDH1 IDH2	9.86e-04	7	205	2	C0344461
Disease	Mixed Oligodendroglioma-Astrocytoma	IDH1 IDH2	9.86e-04	7	205	2	C0280793
Disease	Mixed Oligodendroglioma-Ependymoma	IDH1 IDH2	9.86e-04	7	205	2	C0751395
Disease	Well Differentiated Oligodendroglioma	IDH1 IDH2	9.86e-04	7	205	2	C0751396
Disease	Epilepsy	CHD2 UBE3A FLNA ASTN1 KCNH5	1.00e-03	109	205	5	C0014544
Disease	selenium measurement	FOXN3 ADGRL2 MYOM2	1.06e-03	29	205	3	EFO_0006331
Disease	MYELODYSPLASTIC SYNDROME	MECOM FANCC FANCB TLR2	1.23e-03	67	205	4	C3463824
Disease	hepatocellular carcinoma (is_marker_for)	PRDM1 ASPM DNMT3B IDH2 GSTP1 IGF2R CSK REG3A	1.27e-03	301	205	8	DOID:684 (is_marker_for)
Disease	cutaneous mastocytosis	CNTN6 TMEM182 POLQ	1.29e-03	31	205	3	EFO_1000886
Disease	Ehlers-Danlos syndrome	COL3A1 COL5A2	1.31e-03	8	205	2	cv:C0013720
Disease	Uveal melanoma	GNA11 GNAQ	1.31e-03	8	205	2	C0220633
Disease	Lymphoid leukemia	MECOM POT1	1.31e-03	8	205	2	C0023448
Disease	prostate cancer (is_implicated_in)	CHD1 SULT2A1 GSTP1 PEBP1 TLR2	1.38e-03	117	205	5	DOID:10283 (is_implicated_in)
Disease	prostate cancer (implicated_via_orthology)	CHD1 CHD2 MEP1B	1.55e-03	33	205	3	DOID:10283 (implicated_via_orthology)
Disease	Ehlers-Danlos syndrome (is_implicated_in)	COL3A1 COL5A2	1.67e-03	9	205	2	DOID:13359 (is_implicated_in)
Disease	Endomyocardial Fibrosis	COL3A1 IGF2R	1.67e-03	9	205	2	C0553980
Disease	systolic blood pressure, body mass index	ADGRB3 TMEM182 CSK	1.69e-03	34	205	3	EFO_0004340, EFO_0006335
Disease	chronic rhinosinusitis	NEK6 TMEM232 TSLP	1.69e-03	34	205	3	EFO_1000024
Disease	Keloid	FOXL2 COL3A1 CRABP1	1.84e-03	35	205	3	C0022548
Disease	cholesteryl ester 16:0 measurement	CNTN6 ADGRL3 AMT	1.99e-03	36	205	3	EFO_0010341
Disease	triacylglycerol 54:1 measurement	SAMHD1 IGF2R	2.08e-03	10	205	2	EFO_0010419
Disease	diet measurement	MYT1L ANKUB1 ADGRB3 CHD2 CNTN6 PTPRA GPC5 GNAQ ADGRL2 DNMT3B DPEP1 TMEM182 SAMHD1 GRM5 NBAS PTCD1	2.83e-03	1049	205	16	EFO_0008111
Disease	Cutaneous Melanoma	DDB2 GNA11 GNAQ	2.90e-03	41	205	3	C0151779
Disease	pulmonary function measurement, forced expiratory volume, smoking behaviour measurement	MECOM INTS12	3.03e-03	12	205	2	EFO_0003892, EFO_0004314, EFO_0005671
Disease	Hematologic Neoplasms	IDH1 IDH2	3.03e-03	12	205	2	C0376545
Disease	diffuse large B-cell lymphoma (is_implicated_in)	GSTP1 CD22	3.03e-03	12	205	2	DOID:0050745 (is_implicated_in)
Disease	high grade glioma (is_implicated_in)	POT1 IDH1 GSTP1	3.11e-03	42	205	3	DOID:3070 (is_implicated_in)
Disease	high grade glioma (implicated_via_orthology)	IDH1 IDH2 MAPKBP1	3.55e-03	44	205	3	DOID:3070 (implicated_via_orthology)
Disease	Colorectal Carcinoma	EPHB6 EML2 CHD1 FOXL2 COL3A1 DPEP1 IDH1 CUBN LIG3 TLR2 NEURL1 OLFM2	3.87e-03	702	205	12	C0009402
Disease	urokinase plasminogen activator surface receptor measurement	ASGR1 LY75	4.14e-03	14	205	2	EFO_0010932
Disease	trimethylamine-N-oxide measurement	CUBN ST18	4.14e-03	14	205	2	EFO_0010541
Disease	Fanconi anemia	FANCC FANCB	4.14e-03	14	205	2	cv:C0015625
Disease	severe combined immunodeficiency (is_implicated_in)	ZAP70 DCLRE1C	4.14e-03	14	205	2	DOID:627 (is_implicated_in)
Disease	lobe size	SULT1C4 ADGRG6	4.14e-03	14	205	2	EFO_0007666
Disease	urate measurement, bone density	ADGRB3 TOX4 KIDINS220 RABGAP1L SUMF1 ALG8 GPC5 CHODL FBRSL1 UGGT2 KCNH5	4.21e-03	619	205	11	EFO_0003923, EFO_0004531
Disease	Non-steroidal anti-inflammatory and antirheumatic product use measurement	TRIM26 CSK	4.75e-03	15	205	2	EFO_0009935
Disease	head and neck squamous cell carcinoma (is_implicated_in)	FANCB DNMT3B	4.75e-03	15	205	2	DOID:5520 (is_implicated_in)
Disease	cholesterol in medium LDL measurement	IGF2R ASGR1 CEACAM20	4.81e-03	49	205	3	EFO_0022224
Disease	response to tenofovir	KIDINS220 ADGRL2 CRABP1	5.39e-03	51	205	3	EFO_0009279
Disease	Chromosome Aberrations	POT1 GSTP1	5.41e-03	16	205	2	C0008625
Disease	Blood Coagulation Disorders	GNAQ COL5A2	5.41e-03	16	205	2	C0005779
Disease	Autosome Abnormalities	POT1 GSTP1	5.41e-03	16	205	2	C0004403
Disease	dyslexia	PTPRA GNAQ ADGRL2 DNMT3B TMEM182	5.59e-03	162	205	5	EFO_0005424
Disease	total lipids in medium LDL	IGF2R ASGR1 CEACAM20	5.69e-03	52	205	3	EFO_0022180
Disease	suntan	DNMT3B DPEP1 SAMHD1 GRM5	5.86e-03	103	205	4	EFO_0004279
Disease	Familial thoracic aortic aneurysm and aortic dissection	COL3A1 COL5A2 FLNA	6.00e-03	53	205	3	C4707243
Disease	metabolite measurement	MYT1L NCBP1 MFSD4B SULT2A1 ALCAM DPEP1 THEM5 GSTP1 NBAS IGF2R	6.04e-03	560	205	10	EFO_0004725
Disease	Antibody Deficiency Syndrome	DNMT3B ZAP70	6.10e-03	17	205	2	C0003257
Disease	white matter microstructure measurement	KLHL24 MECOM DPEP1 COL5A2 MED8 OR2J3 ADGRG6 SEMA3D	6.16e-03	390	205	8	EFO_0005674
Disease	hair color	NEK6 ADGRV1 FZD1 TYRP1 EML5 DPEP1 GRM5	6.26e-03	311	205	7	EFO_0003924
Disease	Bone marrow hypocellularity	FANCC FANCB	6.83e-03	18	205	2	C1855710

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGKAWADADNYCRLE	ASGR1	171	P07306
NAYVWAPGALKVLEC	EDDM3A	91	Q14507
CTGKVWQLDYESEPL	FCER1A	176	P12319
DPYRAVVKVSTCWEG	FBRSL1	531	Q9HCM7
FDCGAKNPSWASITY	ARFGAP3	26	Q9NP61
VAIWVGTCSDYPKGD	CTHRC1	211	Q96CG8
GTAAEAKLQEPWSCY	DNMT3B	511	Q9UBC3
NPYCVLWDDSKTNES	ADGRB3	816	O60242
YWGPVDISNCLKEAN	ADGRG6	571	Q86SQ4
LTLQCWAESKPGAEY	CEACAM20	371	Q6UY09
LCANYLLEETWGKPS	ERO1B	261	Q86YB8
GAWCKDPLQASDKIY	ADGRL3	156	Q9HAR2
VNVYWKASPDSAGLE	ADGRV1	3951	Q8WXG9
TCYWEAGPSVGAKLS	CFAP46	1976	Q8IYW2
SPCIYEAEQKAGAWC	ADGRL2	146	O95490
AAWPSGTECIAKYNF	CSK	6	P41240
QGPKYKWICATEIED	ECT2L	871	Q008S8
LPYSECSWEDGALIS	CHD1	416	O14646
EWYKASGLACSQEAE	ASPM	2796	Q8IZT6
GFEESCSIWYPNKQV	ASTN1	871	O14525
ADCGAADPDWASYKL	ADAP2	26	Q9NPF8
ADPDWASYKLGIFIC	ADAP2	31	Q9NPF8
CWALSYLSDGPNDKI	KPNA5	276	O15131
WQLYTSAQAPDGKCI	OLFM2	31	O95897
CTQTLLEGDGPKTYW	CRABP1	96	P29762
LIYGCKDARSPVADW	IPPK	216	Q9H8X2
AIKSLWNDPGIQECY	GNAQ	131	P50148
TDKEANDPRLVWYCA	INTS12	196	Q96CB8
AVNSAASLWGPYKDI	NUP205	6	Q92621
CIDASQPDVGSWLKY	MECOM	136	Q03112
DSEWYPSEAKVLCQS	CD6	291	P30203
ERPQKTASNCYITGW	PRSS12	756	P56730
GVKQCDRYWPDEGAS	PTPRN	816	Q16849
SSPEENWPACQKAYN	KIDINS220	1661	Q9ULH0
EYTCKACQLGSWPTD	GRM5	546	P41594
LYWNLDKENPSGCSE	LAMA3	616	Q16787
YNWRCPGTDSEKVGL	NMT2	481	O60551
DGTSVLTPWYKNCIE	NCBP1	731	Q09161
LPCWNGEDIVKSYTQ	GPC5	416	P78333
ECENGSYKPGWLVTL	GPR158	271	Q5T848
RYSCKASNEVGEDWL	HMCN2	2826	Q8NDA2
CVYGRNLEPSKWTAI	TMPRSS15	826	P98073
VDWPVVYSNDGFCKL	KCNH5	36	Q8NCM2
CLSKEWGSFLEESYP	DDX60	126	Q8IY21
KEGDSGLYWCEVAPE	FCRL6	171	Q6DN72
ANIKEQSDFCPWYTG	GSPT2	396	Q8IYD1
NKPYDVFGCWLTETS	FBXW5	186	Q969U6
SGKKPWYLEECSSTL	PCSK5	341	Q92824
SATENGYKPWYLEEC	PCSK6	371	P29122
CWEKYLEETGASAVP	L3MBTL1	491	Q9Y468
ACPEAWGAAYSLFVV	OR51S1	196	Q8NGJ8
PDEQKACWFILAAIY	MYO18A	656	Q92614
GTCYQAEWDDYVPKL	PEBP1	166	P30086
GERKGNYWTLDPACE	FOXL2	121	P58012
TFDKYSCWPDTPANT	GCGR	61	P47871
KLDLSYNDSICDAGW	LRRC31	456	Q6UY01
DNRPQGWCLSDTYLK	MED23	1036	Q9ULK4
DTYLEREWGNKPSDC	OBI1	361	Q5W0B1
ENGYNFKSDIWSLGC	NEK6	221	Q9HC98
PEEWYEGVCEIATKS	PI4KA	816	P42356
SVLCYDPVAAKWNEV	KLHL41	416	O60662
SPDGLACDWLGEKLY	LRP6	96	O75581
NWSPEAYCLVGSEVL	LRRK2	1741	Q5S007
YSPDSAAKVQCSEQW	LY75	941	O60449
IPEGDCATKQEYWSN	CD200R1	181	Q8TD46
QCEVDSLAGWKPSVY	KCNK13	181	Q9HB14
PASWIYSDQKCDGTN	LDLRAD1	131	Q5T700
TAPSGCLSFWEAKAQ	NAGS	181	Q8N159
ILSYYDSPEDAWKGC	PLEKHA8	26	Q96JA3
RDDPGKGSYWTIDTC	FOXJ2	131	Q9P0K8
YTSEKEEGTPWNEDC	NOL8	1006	Q76FK4
EEAGCSPKTERYSWQ	PLA2G10	96	O15496
EIRVYSASQWDCPLG	DDB2	311	Q92466
YDPGSQKWCTVTKCA	LIG3	716	P49916
GYPKSWDVCSQLGQS	NBAS	1311	A2RRP1
GANLKEQSDFCPWYI	GSPT1	266	P15170
KTGYAFVDCPDESWA	IGF2BP3	36	O00425
NLPYNNKSDIWSLGC	NEK3	176	P51956
DKNPICLWIATSVYG	MFSD4B	316	Q5TF39
VSKDCPEKILYSWGE	RABGAP1L	501	Q5R372
NLWASDKGTYICEAE	HMCN1	856	Q96RW7
YTCEKALSHPWIDGN	CAMK1G	266	Q96NX5
LKVEVCGTSWTYNPA	MIB1	381	Q86YT6
QLSSVEKDYPDTWVC	MORC2	511	Q9Y6X9
CTQEPSKSDYAIWNT	FANCB	196	Q8NB91
AQKPYSKAVDCWSIG	CAMK1	191	Q14012
WSEPVLLAKGSCAYS	NEU2	321	Q9Y3R4
NLYDSCVDDTWNPKI	PARP11	306	Q9NR21
DSYGLVCNKPTVWVL	KCTD18	131	Q6PI47
AELDLWSKAPASCYI	PLA2G4C	441	Q9UP65
WSKAPASCYILKGET	PLA2G4C	446	Q9UP65
WPDNYDNDKDCTVTL	CUBN	3411	O60494
ERSWVAQSCKSYAIP	FZD1	566	Q9UP38
LEQYGQCVAAKPESW	CHCHD5	16	Q9BSY4
TEQAPLWAYIACACG	CEPT1	111	Q9Y6K0
IWACKNYDGDVQSDS	IDH1	266	O75874
WACKNYDGDVQSDIL	IDH2	306	P48735
SDTEAGKYQCVAELW	IGSF3	636	O75054
YSYVCGISSKDEPDW	GMPS	526	P49915
YTECYDPVTGEWKSL	KLHL24	331	Q6TFL4
EQEAGVLCKPWYAGA	BLNK	336	Q8WV28
AEEYFQWSKLPCGIT	DCLRE1C	261	Q96SD1
DQYCEKSAALTWLIP	GATAD1	176	Q8WUU5
SPDYKSNAVDGQWGC	C6	556	P13671
LKCEDGYTLEGSPWS	CR1	1936	P17927
WLGKVSPEDVEYFNC	CHD2	351	O14647
PYSECSWEDEALIGK	CHD2	421	O14647
AGTYWCEVFNPISKN	CEACAM1	391	P13688
RCIKQGENWYSPTEF	DEAF1	226	O75398
KGDGSCDVRYWPQEA	FLNA	626	P21333
AQPKCTYENVTGGLW	FRS3	281	O43559
QSIGKGSLWCIDPEY	FOXN3	181	O00409
SLEQSYEDPKVACWL	POLQ	1981	O75417
YCTSKDDQVGIWSGP	CR1L	206	Q2VPA4
AIKTLWEDPGIQECY	GNA11	131	P29992
YCEAASLLGNSWDKG	GUCY2F	131	P51841
LAKACWNPFILAYDE	FANCC	71	Q00597
SSVPWKYFLNTCGTD	GCNT3	216	O95395
LPSKGDRNVIYTDCW	F11	501	P03951
VETWQEGSLKASCLY	GSTP1	36	P09211
GPAKVDCWNEYFSKS	CFAP97D1	91	B2RV13
LCHSAKQSGEYWIDP	COL5A2	1301	P05997
IYDNLLWECKASGKP	CNTN6	331	Q9UQ52
PSWKYTAIGCQDRNI	MAPKBP1	626	O60336
ELKSGEYWVDPNQGC	COL3A1	1271	P02461
GDYEILYWDPATCKQ	EML2	526	O95834
LYWDPATCKQITSAD	EML2	531	O95834
ISWDLYQPNKLVSCG	EML5	156	Q05BV3
YVVSNAGCWEKDLAL	AMT	141	P48728
ACLWGEYVDATNLTP	HEXB	486	P07686
WSVYTPCDTQNKDAV	DPEP1	81	P16444
DTDTCQDGWIYPDAK	SLC22A14	151	Q9Y267
DCISEDSYPDGNITW	ALCAM	156	Q13740
KTCIDFKPWAGETNY	MEP1B	101	Q16820
PVCTTWKQEAEGAIY	POPDC3	16	Q9HBV1
VEDSLYWECRASGKP	CNTN3	331	Q9P232
LEPVKVQHSGAYWCQ	CD22	646	P20273
EKCAQYWPSDGLVSY	PTPRA	641	P18433
CKLENEYGRLTWPSV	MED8	31	Q96G25
VNLWGPEKTISYAGC	OR2J3	86	O76001
YTNWAADEPKLKSAC	MRC1	1176	P22897
PELCSYTWEAVDTKN	IGF2R	46	P11717
YFSWDSRAACAVKPQ	IGF2R	2116	P11717
ESWKTTPYQIACGIS	TARS1	96	P26639
LEGEDCKVLPDYSGW	TAFA4	111	Q96LR4
CYALFLSPKSWTDAD	REG3A	51	Q06141
KDCDPGEVNKAYWRS	MRPL39	131	Q9NYK5
KEACDWLRAAGFPQY	STARD13	61	Q9Y3M8
DDIVLASYPKCGSNW	SULT6B1	56	Q6IMI4
VKYNSCADRPFSAPW	POMT2	211	Q9UKY4
AVTKDDGCYRGEPSW	TAGLN3	136	Q9UI15
DYKTWGPEQVCSFLR	SAMHD1	41	Q9Y3Z3
WYQSFLKDCPTGRIT	RCVRN	31	P35243
DWTQQCISKGLTYPD	RESF1	196	Q9HCM1
AGKEEWEVNPLYCDT	FAM20A	366	Q96MK3
AWSKDINAYNCEEPT	PRDX6	81	P30041
DSPQAWLSAIGLECY	EPHB6	951	O15197
PDWSKINCSDGYIEY	PLPP1	136	O14494
EWIYCPGDAISSVAA	PPWD1	181	Q96BP3
PWLECFIKSYNVTNG	POT1	601	Q9NUX5
CWQYTSEGREPKLND	MAPKAP1	211	Q9BPZ7
SEAPNSWIVEDKYVC	SLFN11	326	Q7Z7L1
DKCSAIWSEDGCIYP	SMN1	96	Q16637
EKCTYIVNDHPWDSG	PRDM1	56	O75626
TYPKSGTNWLAEILC	SULT2A1	41	Q06520
CSWEDEPELTAAYGA	PLA2G3	71	Q9NZ20
AYCTWAGKRLPTEAE	SUMF1	216	Q8NBK3
AGKRLPTEAEWEYSC	SUMF1	221	Q8NBK3
EAPLAKWSCVAAGFA	SLC39A2	286	Q9NP94
KYGDPITQCWDIEDS	SEMA3D	576	O95025
CDQEGWDTPINYSKT	ST18	661	O60284
SYCFTANKPDGSIRW	ALG8	216	Q9BVK2
TTPACASPSNWKDYD	ANKFN1	361	Q8N957
SGKTPWENAIYCLAV	ANKUB1	486	A6NFN9
KVAWSPCGNYLASAS	CIAO1	66	O76071
LASACPGWICYAEKT	CIAO3	186	Q9H6Q4
NWYTDEPSCGSEKCV	CHODL	131	Q9H9P2
QWDSPAPDTYQKCLS	CLEC9A	11	Q6UXN8
PLNKTWAEADLYCSE	CLEC19A	56	Q6UXS0
CEQKVSDGKYWIDPN	COL24A1	1551	Q17RW2
RFQPYCDSWSDVSLK	ZBTB25	391	P24278
YCIPEGTKFDTLWQL	ZAP70	221	P43403
LPYWNFATGKNVCDI	TYRP1	246	P17643
QCYWKSGEPQSDDIE	UBE3A	6	Q05086
SYDCTVKLWDPVDGS	WDR88	121	Q6ZMY6
YSWEGNPINISCDVK	NCAM2	411	O15394
YACPDLVSQSGFWAK	NEURL1	141	O76050
PDIYAAGDICTTSWQ	PYROXD1	351	Q8WU10
DLKDYALPNASWCSD	THEM5	51	Q8N1Q8
KYWLSQEEADKCSPN	SMRP1	86	Q8NCR6
PAAWTEVIYLAQCKG	TMEM232	96	C9JQI7
CSAGPKGDNIYEWRS	UBE2E3	81	Q969T4
YVKGILQPTDTCDIW	SULT1C4	21	O75897
ISCNYKSNTIEPFWD	USP49	456	Q70CQ1
KTKAALAIWCPGYSE	TSLP	101	Q969D9
SASGYLQLSEDWKCV	TRIM26	321	Q12899
NEPKVWYVSLACSKD	UBE3B	111	Q7Z3V4
SCLPATAGFSYEKWE	TXK	251	P42681
LETWIAKEDCPLYNG	ZFAND1	231	Q8TCF1
RKPSVQWSDTAEYFC	TRAV8-1	96	A0A0A6YYK1
ENDDLYITWPTSCQK	UGGT2	451	Q9NYU1
QEIWCLAVSPSGDYV	WDR3	676	Q9UNX4
YTALFNVCAESPWKD	PTCD1	211	O75127
QIDELPTYWSECGKN	TUT7	1216	Q5VYS8
KDCLDFTPSVLYGWS	TMEM182	186	Q6ZP80
YLKNSACEDAWPSLQ	TLR2	376	O60603
PGSLYTCSVWVEKDG	PTPRH	91	Q9HD43
PIVSKDWDNEYCSNE	TOX4	581	O94842
SCDDPEVEDYGNKWS	TTLL5	281	Q6EMB2
AVDYNTCAGVWSQDK	YTHDF2	476	Q9Y5A9
GEPCDLSLNITWYLK	TMEM87A	71	Q8NBN3
DLGPCTSKWTVDYLS	TYW5	36	A2RUC4
QWPAVYKAGDKDCLA	TMEM145	81	Q8NBT3
QWYKDGSLICQAAEP	MYOM2	186	P54296
LGEGDCWDLPVDYTK	MYT1L	811	Q9UL68
QQGLSPWYAEKCSST	PCSK1	336	P29120